Investments, Funding & Disinvestment

The organization plans to construct the country’s first dedicated facility for treating Sickle Cell Disease and blood cancers, which will offer life-saving bone-marrow transplants that are currently unavailable within Uganda’s borders.

The initiative supports the World Bank Group’s ambitious goal of delivering quality health services to 1.5 billion people by 2030.

Through its wholly owned healthcare subsidiary, NSIA Advanced Medical Services Limited (MedServe), the Authority has partnered with GE HealthCare to launch an ambitious diagnostic services expansion program.

The newly formed partnership, operating as SNG Health, represents the first direct investment of its kind in mosquito net production within the country.

The partnership will begin with a study focused on assessing Mirai’s ability to predict breast cancer risk specifically in Japanese women using mammography images.

The two pharmaceutical giants originally signed the agreement in October 2025, establishing a framework centered on bispecific antibodies and ADCs.

Morocco’s pledge is timely, as Gavi prepares to implement its next strategic phase, known as “Gavi 6.0,” which aims to protect 500 million children between 2026 and 2030

The funding will focus on preventing and managing diseases such as HIV/AIDS, tuberculosis (TB), and malaria, as well as improving maternal and child health, eradicating polio, strengthening disease surveillance, and enhancing preparedness for infectious disease outbreaks.

Regeneron is investing USD 150 million in equity and upfront payments to acquire half of the global development and commercialization rights for TSRA-196.

The closure announcement follows Valneva’s financial results for the first nine months of 2025, which revealed mixed performance.